Director Thomas Clay Kahler filed a Form 4 with the SEC on October 27, 2026, disclosing the grant of a stock option to purchase 53,763 shares of Canton Strategic Holdings, Inc. common stock, with a transaction date of October 23, 2026.

Key Highlights

  • New option grant: Kahler received a stock option (right to buy) covering 53,763 shares of common stock at an exercise price of $1.86, granted October 23, 2026, and expiring October 23, 2036.
  • Vesting schedule: According to the filing, 40,322 shares vest on October 23, 2026, and the remaining 13,441 shares vest on January 1, 2027, subject to continuous service as a board member.
  • Plan and policy basis: The option was granted under the issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan and pursuant to the issuer's Non-Employee Director Compensation Policy as an annual director equity grant.
  • Pre-existing options retained: Kahler also holds a previously reported option for 50,000 shares at $1.33, and another for 17,500 shares at $3.075, both also listed in the filing.
  • Reporting person role: Kahler is identified as a Director of Canton Strategic Holdings, Inc. (NASDAQ:CNTN).

Details of Kahler's October 2026 Director Option Award at Canton Strategic Holdings

According to the Form 4 filed on October 27, 2026, Thomas Clay Kahler, a director of Canton Strategic Holdings, Inc. (NASDAQ:CNTN), acquired a stock option to purchase 53,763 shares of the company's common stock. The transaction code listed is "A" (acquired), with a transaction date of October 23, 2026. The exercise price of the newly granted option is $1.86 per share, and the option expires on October 23, 2036. The filing states the option was issued as an annual director equity grant under the issuer's Non-Employee Director Compensation Policy.

The filing's explanation of responses notes that 40,322 of the 53,763 option shares vest on October 23, 2026, while the remaining 13,441 shares are scheduled to vest on January 1, 2027. Both tranches are subject to the reporting person's continuous service as a member of the issuer's board of directors immediately prior to each applicable vesting date. The option was granted under the issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan, as the filing discloses.

In addition to the new grant, the filing reports two previously held derivative positions. A previously reported option for 50,000 shares at an exercise price of $1.33, originally granted August 4, 2025, is disclosed as fully vested in two equal tranches of 25,000 shares each - the first on the grant date and the second on August 4, 2026. A separate option for 17,500 shares at $3.075, with a transaction date of November 3, 2025, and expiring November 3, 2035, is also listed. All three options are held directly by the reporting person.

What Was Disclosed

The filing disclosed the acquisition of a new 53,763-share stock option at $1.86 by director Thomas Clay Kahler on October 23, 2026, as an annual director equity grant, along with details of two pre-existing option holdings, resulting in total direct beneficial ownership of 121,263 derivative shares.